Mio Nakamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mio Nakamura has a total of 260 co-authors. Here are the top co-authors by number of shared publications:
John Koo
Department of Dermatology, University of California San Francisco, San Francisco, CA, USA
20 shared publicationsTina Bhutani
A Department of Dermatology , University of California San Francisco , San Francisco , CA , USA
19 shared publicationsTian Hao Zhu
14 shared publicationsBenjamin Farahnik
Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA
13 shared publicationsMichael Abrouk
University of California – Irvine, School of Medicine, Irvine, California
11 shared publicationsKristina Lee
Department of Dermatology, University of California San Francisco, San Francisco, CA, USA
10 shared publications
Latest Publications
- Open Access
- 22 September 2026
- Published by Wiley in Photochemistry and Photobiology
UV signature mutation hyperhotspots as genomic dosimeters
Screening for UV‐sensitive DNA mutation sites as dosimeters for individual sun exposure, using high‐fidelity Duplex Sequencing to reduce false positives and a stringent genome alignment protocol to reduce false negatives, revealed: (i) Sun‐exposed human skin contained UV signature mutations (C → T at a diypyrimidine) >1000‐fold more frequently than unexposed neonatal skin, making these mutations sensitive genomic dosimeters for UV exposure. (ii) Tumor suppressor gene hotspot nucleotides (nt) reached variant allele frequency (VAF) 0.1%–10% via 30–3000 fold clonal expansion in occasional biopsies, due to being cancer drivers. (iii) Cyclobutane pyrimidine dimer (CPD) hyperhotspots attained those frequencies in nearly every biopsy, due to profuse creation plus ~30‐fold clonal expansion. (iv) Neonatal keratinocyte cultures exposed to weeks of low‐dose UVB exposure developed mutations at skin cancer tumor suppressor gene hotspot nt rarely and randomly, as expected. (v) CPD hyperhotspots in gene promoters acquired mutations in days at 1000‐fold higher frequencies. Sun exposure is the strongest risk factor for skin cancer, so quantifiable UV signature mutations at CPD hyperhotspots in normal skin may make it technically feasible to identify individuals in need of monitoring to ensure early detection.
- 22 September 2026
- Published by Wiley in Photochemistry and Photobiology
Open AccessUV signature mutation hyperhotspots as genomic dosimeters
Screening for UV‐sensitive DNA mutation sites as dosimeters for individual sun exposure, using high‐fidelity Duplex Sequencing to reduce false positives and a stringent genome alignment protocol to reduce false negatives, revealed: (i) Sun‐exposed human skin contained UV signature mutations (C → T at a diypyrimidine) >1000‐fold more frequently than unexposed neonatal skin, making these mutations sensitive genomic dosimeters for UV exposure. (ii) Tumor suppressor gene hotspot nucleotides (nt) reached variant allele frequency (VAF) 0.1%–10% via 30–3000 fold clonal expansion in occasional biopsies, due to being cancer drivers. (iii) Cyclobutane pyrimidine dimer (CPD) hyperhotspots attained those frequencies in nearly every biopsy, due to profuse creation plus ~30‐fold clonal expansion. (iv) Neonatal keratinocyte cultures exposed to weeks of low‐dose UVB exposure developed mutations at skin cancer tumor suppressor gene hotspot nt rarely and randomly, as expected. (v) CPD hyperhotspots in gene promoters acquired mutations in days at 1000‐fold higher frequencies. Sun exposure is the strongest risk factor for skin cancer, so quantifiable UV signature mutations at CPD hyperhotspots in normal skin may make it technically feasible to identify individuals in need of monitoring to ensure early detection.
- Open Access
- 11 May 2026
- Published by Dermsquared in SKIN The Journal of Cutaneous Medicine
- Vol. 10 (3) , 3072-3081
Patient Characteristics and Treatment Approaches in Delusional Infestation Across Two Medical Centers: A Retrospective Study
Background: Delusional Infestation (DI) is a psychiatric disorder marked by persistent, false belief of infestation despite medical evidence to the contrary. Large-scale research on DI is limited, with only one population-based study to date. DI remains poorly understood and difficult to manage. Methods: We conducted a multicenter retrospective chart review of adult outpatients seen in tertiary dermatology clinics at the University of Michigan and University of California, San Francisco between January 2021 and May 2024. Patients were identified using relevant ICD codes, and eligibility was confirmed by manual review for DSM-5 criteria for DI. Key clinical and demographic data were extracted, and relevant risk was calculated using national prevalence data from NAMI and SAMHSA. Results: We identified 155 patients with DI; most were female (79%), non-Hispanic (94%), and white (73%). Mean age of onset was 54 years, with a three-year diagnostic delay. Delusions commonly involved parasites (25%) or bugs/insects (27%). Diagnostic evaluations included skin biopsy (34%) and skin scrapings (15%), with significant variation between centers. Substance use and psychiatric comorbidities were prevalent, with elevated relative risks compared to population data. Treatments most often involved antiparasitic agents, pimozide, or second-generation antipsychotics; pimozide was associated with the highest rate of improvement Conclusions: DI primarily affects middle-aged female and is marked by delayed diagnosis, frequent substance use, and psychiatric comorbidities. Despite varied diagnostic approaches, treatment outcomes remain poor. Multidisciplinary care and standardized protocols are needed to improve management and outcomes.
- 11 May 2026
- Published by Dermsquared in SKIN The Journal of Cutaneous Medicine
- Vol. 10 (3) , 3072-3081
Open AccessPatient Characteristics and Treatment Approaches in Delusional Infestation Across Two Medical Centers: A Retrospective Study
Background: Delusional Infestation (DI) is a psychiatric disorder marked by persistent, false belief of infestation despite medical evidence to the contrary. Large-scale research on DI is limited, with only one population-based study to date. DI remains poorly understood and difficult to manage. Methods: We conducted a multicenter retrospective chart review of adult outpatients seen in tertiary dermatology clinics at the University of Michigan and University of California, San Francisco between January 2021 and May 2024. Patients were identified using relevant ICD codes, and eligibility was confirmed by manual review for DSM-5 criteria for DI. Key clinical and demographic data were extracted, and relevant risk was calculated using national prevalence data from NAMI and SAMHSA. Results: We identified 155 patients with DI; most were female (79%), non-Hispanic (94%), and white (73%). Mean age of onset was 54 years, with a three-year diagnostic delay. Delusions commonly involved parasites (25%) or bugs/insects (27%). Diagnostic evaluations included skin biopsy (34%) and skin scrapings (15%), with significant variation between centers. Substance use and psychiatric comorbidities were prevalent, with elevated relative risks compared to population data. Treatments most often involved antiparasitic agents, pimozide, or second-generation antipsychotics; pimozide was associated with the highest rate of improvement Conclusions: DI primarily affects middle-aged female and is marked by delayed diagnosis, frequent substance use, and psychiatric comorbidities. Despite varied diagnostic approaches, treatment outcomes remain poor. Multidisciplinary care and standardized protocols are needed to improve management and outcomes.
- Open Access
- 12 January 2026
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 9, e76674
Leveraging AI Large Language Models for Writing Clinical Trial Proposals in Dermatology: Instrument Validation Study
Background: Large language models (LLMs) are becoming increasingly popular in clinical trial design but have been underused in research proposal development. Objective: This study compared the performance of commonly used open access LLMs versus human proposal composition and review. Methods: A total of 10 LLMs were prompted to write a research proposal. Six physicians and each of the LLMs assessed 11 blinded proposals for capabilities and limitations in accuracy and comprehensiveness. Results: ChatGPT-o1 and Llama 3.1 were rated the most and least accurate, respectively, by human scorers. LLM scorers rated ChatGPT-o1 and DeepSeek R1 as the most accurate. ChatGPT-o1 and Llama 3.1 were rated as the most and least comprehensive, respectively, by human and LLM scorers. LLMs performed poorly on scoring proposals and, on average, rated proposals 1.9 points higher than humans for both accuracy and comprehensiveness. Conclusions: Paid versions of ChatGPT remain the highest-quality and most versatile option of the available LLMs. These tools cannot replace expert input but serve as powerful assistants, streamlining the development process and enhancing productivity.
- 12 January 2026
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 9, e76674
Open AccessLeveraging AI Large Language Models for Writing Clinical Trial Proposals in Dermatology: Instrument Validation Study
Background: Large language models (LLMs) are becoming increasingly popular in clinical trial design but have been underused in research proposal development. Objective: This study compared the performance of commonly used open access LLMs versus human proposal composition and review. Methods: A total of 10 LLMs were prompted to write a research proposal. Six physicians and each of the LLMs assessed 11 blinded proposals for capabilities and limitations in accuracy and comprehensiveness. Results: ChatGPT-o1 and Llama 3.1 were rated the most and least accurate, respectively, by human scorers. LLM scorers rated ChatGPT-o1 and DeepSeek R1 as the most accurate. ChatGPT-o1 and Llama 3.1 were rated as the most and least comprehensive, respectively, by human and LLM scorers. LLMs performed poorly on scoring proposals and, on average, rated proposals 1.9 points higher than humans for both accuracy and comprehensiveness. Conclusions: Paid versions of ChatGPT remain the highest-quality and most versatile option of the available LLMs. These tools cannot replace expert input but serve as powerful assistants, streamlining the development process and enhancing productivity.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Dermatological Medicine
- Vol. 2026 (1) , 6524620
Leukemia Cutis Exhibiting the Koebner Phenomenon: A Rare Clinical Presentation of Acute Myeloid Leukemia
Leukemia cutis with predilection for sites of prior cutaneous trauma, often described as a Koebner‐like phenomenon, is a rare but recognized occurrence. We present a unique case of an, otherwise, healthy male who developed leukemia cutis at a prior unrelated biopsy site, leading to a new diagnosis of acute myeloid leukemia (AML). Certain AML subtypes with extramedullary propensity, particularly M4 and M5, as seen in our patient, are associated with an increased risk of leukemia cutis. Unlike their medullary counterparts, extramedullary AML cells preferentially migrate to and persist in tissues outside the bone marrow, where the local microenvironment may promote immune escape. Although the localization of leukemia cutis to the biopsy site is consistent with a Koebner‐like response, it remains uncertain whether subclinical leukemic cells were already present at the time of the initial excision; therefore, a definitive causal relationship between trauma and leukemic infiltration cannot be established. Additionally, the prior keratoacanthoma and its excision may have created a localized immunocompromised cutaneous district, or locus minoris resistentiae , further predisposing the site to leukemic cell infiltration. The immunologic features of extramedullary AML, including impaired antigen presentation and T‐cell exhaustion, overlap with this concept of localized immune dysregulation and may have facilitated site‐specific leukemic infiltration. New infiltrative plaques at sites of prior skin trauma or biopsy warrant prompt biopsy and histopathological evaluation, even in patients without known hematologic malignancy. Leukemia cutis may represent the first manifestation of underlying acute leukemia, making early recognition critical for timely oncologic referral and treatment.
- 1 January 2026
- Published by Wiley in Case Reports in Dermatological Medicine
- Vol. 2026 (1) , 6524620
Open AccessLeukemia Cutis Exhibiting the Koebner Phenomenon: A Rare Clinical Presentation of Acute Myeloid Leukemia
Leukemia cutis with predilection for sites of prior cutaneous trauma, often described as a Koebner‐like phenomenon, is a rare but recognized occurrence. We present a unique case of an, otherwise, healthy male who developed leukemia cutis at a prior unrelated biopsy site, leading to a new diagnosis of acute myeloid leukemia (AML). Certain AML subtypes with extramedullary propensity, particularly M4 and M5, as seen in our patient, are associated with an increased risk of leukemia cutis. Unlike their medullary counterparts, extramedullary AML cells preferentially migrate to and persist in tissues outside the bone marrow, where the local microenvironment may promote immune escape. Although the localization of leukemia cutis to the biopsy site is consistent with a Koebner‐like response, it remains uncertain whether subclinical leukemic cells were already present at the time of the initial excision; therefore, a definitive causal relationship between trauma and leukemic infiltration cannot be established. Additionally, the prior keratoacanthoma and its excision may have created a localized immunocompromised cutaneous district, or locus minoris resistentiae , further predisposing the site to leukemic cell infiltration. The immunologic features of extramedullary AML, including impaired antigen presentation and T‐cell exhaustion, overlap with this concept of localized immune dysregulation and may have facilitated site‐specific leukemic infiltration. New infiltrative plaques at sites of prior skin trauma or biopsy warrant prompt biopsy and histopathological evaluation, even in patients without known hematologic malignancy. Leukemia cutis may represent the first manifestation of underlying acute leukemia, making early recognition critical for timely oncologic referral and treatment.
- Open Access
- 23 September 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (20)
Th17 cells with regulatory phenotype are the main IL-17F and IL-26 producers in palmoplantar pustulosis
Palmoplantar pustulosis (PPP) is a chronic inflammatory skin disorder marked by erythematous pustules and desquamation on the palms and soles. While IL-17 pathways are implicated in PPP, IL-17 blockers have shown modest efficacy, underscoring the need for a deeper understanding of IL-17 involvement. To dissect the cellular and spatial architecture of PPP, we performed single-cell RNA-Seq (scRNA-Seq) on lesional, nonlesional, and healthy acral skin to examine cellular composition, transcriptomic profiles, and cell-cell interactions. Unbiased clustering revealed 9 major cell types, including an inflammatory keratinocyte subset enriched in IL-17A/TNF signatures and marked by high IL-36G expression. Within the lymphocyte compartment, we identified a hybrid “regTh17” population coexpressing regulatory markers ( FOXP3 , CTLA4 , TIGIT ), IL17F , and IL26 . This regTh17 subset was distinguished by elevated IL1R1 and CD39 , suggesting an IL-1β–driven differentiation. Spatial analyses demonstrated significant neighborhood enrichment of regTh17 cells with IL-36G + supraspinous keratinocytes. RegTh17 cells were the predominant source of IL-17F and IL-26 signals, whereas keratinocytes were predicted as their main receivers. We further observed regTh17 coexpressing TNFRSF4 (OX40) and TNFRSF18 (GITR) specifically at sites of IL36G + keratinocyte interactions, implicating these pathways in amplification of the IL-17/IL-36 inflammatory loop. Together, our integrated single-cell and spatial profiling uncovers Th17 plasticity in PPP, identifies a regTh17-keratinocyte interaction, and highlights IL-17F, IL-26, OX40/OX40L, and GITR/GITRL as candidate targets for precision therapies in this challenging disease.
- 23 September 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (20)
Open AccessTh17 cells with regulatory phenotype are the main IL-17F and IL-26 producers in palmoplantar pustulosis
Palmoplantar pustulosis (PPP) is a chronic inflammatory skin disorder marked by erythematous pustules and desquamation on the palms and soles. While IL-17 pathways are implicated in PPP, IL-17 blockers have shown modest efficacy, underscoring the need for a deeper understanding of IL-17 involvement. To dissect the cellular and spatial architecture of PPP, we performed single-cell RNA-Seq (scRNA-Seq) on lesional, nonlesional, and healthy acral skin to examine cellular composition, transcriptomic profiles, and cell-cell interactions. Unbiased clustering revealed 9 major cell types, including an inflammatory keratinocyte subset enriched in IL-17A/TNF signatures and marked by high IL-36G expression. Within the lymphocyte compartment, we identified a hybrid “regTh17” population coexpressing regulatory markers ( FOXP3 , CTLA4 , TIGIT ), IL17F , and IL26 . This regTh17 subset was distinguished by elevated IL1R1 and CD39 , suggesting an IL-1β–driven differentiation. Spatial analyses demonstrated significant neighborhood enrichment of regTh17 cells with IL-36G + supraspinous keratinocytes. RegTh17 cells were the predominant source of IL-17F and IL-26 signals, whereas keratinocytes were predicted as their main receivers. We further observed regTh17 coexpressing TNFRSF4 (OX40) and TNFRSF18 (GITR) specifically at sites of IL36G + keratinocyte interactions, implicating these pathways in amplification of the IL-17/IL-36 inflammatory loop. Together, our integrated single-cell and spatial profiling uncovers Th17 plasticity in PPP, identifies a regTh17-keratinocyte interaction, and highlights IL-17F, IL-26, OX40/OX40L, and GITR/GITRL as candidate targets for precision therapies in this challenging disease.
- Open Access
- 4 September 2025
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 41 (5) , e70051
Narrowband‐Ultraviolet B Phototherapy for Psoriasis Treatment in Skin of Color: A Systematic Review and Meta‐Analysis
Background: Narrowband‐ultraviolet B (NB‐UVB) phototherapy is an effective treatment for psoriasis in patients who have failed topical regimens or those who desire to avoid systemic treatment. Despite its regular use in non‐white individuals, NB‐UVB treatment response for psoriasis in skin of color (SOC) has not been systematically reviewed. Methods: We conducted a systematic review on the basis of the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) on all available studies to date assessing NB‐UVB for psoriasis treatment in skin of color (SOC) (up to 15 November 2024). The primary outcome was qualitative data on clinical outcomes of UVB (PASI 75). Random‐effects meta‐analysis was performed to assess treatment responses. Secondary outcomes of biochemical and immunologic mechanisms of NB‐UVB, NB‐UVB in combination with other treatments, and NB‐UVB compared to other forms of phototherapy were assessed. Results: Of 1283 articles initially identified, 54 were ultimately included for formal review. We identified 43 articles assessing clinical outcomes of NB‐UVB phototherapy in patients with Fitzpatrick skin type III–IV for a total of 1322 patients with chronic plaque psoriasis and 12 patients with palmoplantar psoriasis. Nine studies were included for meta‐analysis of PASI75 response; 70.5% of patients achieved PASI75, and all studies demonstrated statistically significant PASI improvement after treatment. NB‐UVB demonstrated a higher rate of complete clearance when compared to BB‐UVB but did not result in a statistically significant difference in the proportion of the patient population achieving PASI75 when compared to PUVA. Conclusions: Phototherapy is effective for the treatment of psoriasis in SOC patients and remains a valuable treatment option despite the advent of various topical, systemic, and biologic treatments for psoriasis.
- 4 September 2025
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 41 (5) , e70051
Open AccessNarrowband‐Ultraviolet B Phototherapy for Psoriasis Treatment in Skin of Color: A Systematic Review and Meta‐Analysis
Background: Narrowband‐ultraviolet B (NB‐UVB) phototherapy is an effective treatment for psoriasis in patients who have failed topical regimens or those who desire to avoid systemic treatment. Despite its regular use in non‐white individuals, NB‐UVB treatment response for psoriasis in skin of color (SOC) has not been systematically reviewed. Methods: We conducted a systematic review on the basis of the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) on all available studies to date assessing NB‐UVB for psoriasis treatment in skin of color (SOC) (up to 15 November 2024). The primary outcome was qualitative data on clinical outcomes of UVB (PASI 75). Random‐effects meta‐analysis was performed to assess treatment responses. Secondary outcomes of biochemical and immunologic mechanisms of NB‐UVB, NB‐UVB in combination with other treatments, and NB‐UVB compared to other forms of phototherapy were assessed. Results: Of 1283 articles initially identified, 54 were ultimately included for formal review. We identified 43 articles assessing clinical outcomes of NB‐UVB phototherapy in patients with Fitzpatrick skin type III–IV for a total of 1322 patients with chronic plaque psoriasis and 12 patients with palmoplantar psoriasis. Nine studies were included for meta‐analysis of PASI75 response; 70.5% of patients achieved PASI75, and all studies demonstrated statistically significant PASI improvement after treatment. NB‐UVB demonstrated a higher rate of complete clearance when compared to BB‐UVB but did not result in a statistically significant difference in the proportion of the patient population achieving PASI75 when compared to PUVA. Conclusions: Phototherapy is effective for the treatment of psoriasis in SOC patients and remains a valuable treatment option despite the advent of various topical, systemic, and biologic treatments for psoriasis.
- Open Access
- 28 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Leveraging Artificial Intelligence Large Language Models for Writing Clinical Trial Proposals in Dermatology (Preprint)
BACKGROUND Large language models (LLMs) are becoming increasingly popular in clinical trial design but have been underutilized in research proposal development. OBJECTIVE This study compares the performance of commonly used open access LLMs versus human proposal composition and review. METHODS Ten LLMs were prompted to write a research proposal. Six physicians and each of the LLMs assessed 11 blinded proposals for capabilities and limitations in accuracy and comprehensiveness. RESULTS Chat GPT o1 was rated the most accurate and LLaMA 3.1 the least accurate by human scorers. LLM scorers rated Chat GPT o1 and Deepseek R1 the most accurate. Chat GPT o1 was the most comprehensive and LLaMA 3.1 the least comprehensive by human and LLM scorers. LLMs performed poorly on scoring proposals, and on average rated proposals 1.9 points higher than humans for both accuracy and comprehensiveness. CONCLUSIONS Paid versions of ChatGPT remain the highest quality and most versatile option of available LLMs. These tools cannot replace expert input but serve as powerful assistants, streamlining the development process and enhancing productivity. CLINICALTRIAL n/a
- 28 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessLeveraging Artificial Intelligence Large Language Models for Writing Clinical Trial Proposals in Dermatology (Preprint)
BACKGROUND Large language models (LLMs) are becoming increasingly popular in clinical trial design but have been underutilized in research proposal development. OBJECTIVE This study compares the performance of commonly used open access LLMs versus human proposal composition and review. METHODS Ten LLMs were prompted to write a research proposal. Six physicians and each of the LLMs assessed 11 blinded proposals for capabilities and limitations in accuracy and comprehensiveness. RESULTS Chat GPT o1 was rated the most accurate and LLaMA 3.1 the least accurate by human scorers. LLM scorers rated Chat GPT o1 and Deepseek R1 the most accurate. Chat GPT o1 was the most comprehensive and LLaMA 3.1 the least comprehensive by human and LLM scorers. LLMs performed poorly on scoring proposals, and on average rated proposals 1.9 points higher than humans for both accuracy and comprehensiveness. CONCLUSIONS Paid versions of ChatGPT remain the highest quality and most versatile option of available LLMs. These tools cannot replace expert input but serve as powerful assistants, streamlining the development process and enhancing productivity. CLINICALTRIAL n/a
- Open Access
A Transcriptomic Atlas of Healthy Human Skin Links Regional Identity to Inflammatory Disease
Human skin is not a uniform organ but a mosaic of anatomically distinct niches, with each site finely tuned to unique environmental demands and immune pressures. Yet, the molecular determinants that define these regional identities and their relationship to site-specific vulnerability to inflammatory disease remain poorly understood. Here, we generate a high-resolution single-cell atlas of human skin, profiling 274,834 cells from 96 healthy samples across 7 anatomically distinct sites (acral, arm, axilla, back, face, leg and scalp). Our analysis reveals striking region-specific transcriptional and cellular networks, uncovering how local immune-stromal crosstalk governs tissue homeostasis and underpins anatomical susceptibility to distinct inflammatory diseases such as such as systemic lupus erythematosus (SLE), atopic dermatitis (AD), and psoriasis. These findings illuminate the tissue-intrinsic foundations of regional immune identity and provide a blueprint/resource for the development of precision therapies tailored to the distinct immunological microenvironments of specific anatomical skin sites.
Open AccessA Transcriptomic Atlas of Healthy Human Skin Links Regional Identity to Inflammatory Disease
Human skin is not a uniform organ but a mosaic of anatomically distinct niches, with each site finely tuned to unique environmental demands and immune pressures. Yet, the molecular determinants that define these regional identities and their relationship to site-specific vulnerability to inflammatory disease remain poorly understood. Here, we generate a high-resolution single-cell atlas of human skin, profiling 274,834 cells from 96 healthy samples across 7 anatomically distinct sites (acral, arm, axilla, back, face, leg and scalp). Our analysis reveals striking region-specific transcriptional and cellular networks, uncovering how local immune-stromal crosstalk governs tissue homeostasis and underpins anatomical susceptibility to distinct inflammatory diseases such as such as systemic lupus erythematosus (SLE), atopic dermatitis (AD), and psoriasis. These findings illuminate the tissue-intrinsic foundations of regional immune identity and provide a blueprint/resource for the development of precision therapies tailored to the distinct immunological microenvironments of specific anatomical skin sites.
- Open Access
- 31 January 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (4) , 667-677
Psoriasis in People With Skin of Color: An Evidence‐Based Update
Variations in epidemiology, pathophysiology, genetics, clinical presentation, management, quality of life (QoL) impact, and access to care and research exist globally across the spectrum of individuals with psoriasis. This article aims to provide an evidence‐based update on the characteristics of psoriasis in individuals with skin of color (SOC), a population in which psoriasis data have historically been limited. A literature search was conducted from January 2018 until August 2023 in Pubmed/MEDLINE/Cochrane Library and identified studies with I‐III level of evidence using Oxford Centre for Evidence‐Based Medicine recommendations. Multiple factors (including biological and non‐biological) contribute to differences in clinical features and therapeutic nuances in patient populations with SOC. The prevalence of plaque psoriasis is lower in people with SOC but tends to be more severe. People with SOC are less likely to receive biologic treatment. Although the QoL impact of psoriasis is worse in populations with SOC than in White populations, more research is needed to elucidate variations in presentation and impact across diverse populations. An important limitation of this study is that ethnicity, race, and SOC have not been defined universally or used consistently in the literature. Available evidence provides limited information on populations with SOC outside North America, which limits generalizability across global populations. Furthering our understanding of psoriasis in individuals with SOC is crucial to improving patient care outcomes for diverse patient populations worldwide.
- 31 January 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (4) , 667-677
Open AccessPsoriasis in People With Skin of Color: An Evidence‐Based Update
Variations in epidemiology, pathophysiology, genetics, clinical presentation, management, quality of life (QoL) impact, and access to care and research exist globally across the spectrum of individuals with psoriasis. This article aims to provide an evidence‐based update on the characteristics of psoriasis in individuals with skin of color (SOC), a population in which psoriasis data have historically been limited. A literature search was conducted from January 2018 until August 2023 in Pubmed/MEDLINE/Cochrane Library and identified studies with I‐III level of evidence using Oxford Centre for Evidence‐Based Medicine recommendations. Multiple factors (including biological and non‐biological) contribute to differences in clinical features and therapeutic nuances in patient populations with SOC. The prevalence of plaque psoriasis is lower in people with SOC but tends to be more severe. People with SOC are less likely to receive biologic treatment. Although the QoL impact of psoriasis is worse in populations with SOC than in White populations, more research is needed to elucidate variations in presentation and impact across diverse populations. An important limitation of this study is that ethnicity, race, and SOC have not been defined universally or used consistently in the literature. Available evidence provides limited information on populations with SOC outside North America, which limits generalizability across global populations. Furthering our understanding of psoriasis in individuals with SOC is crucial to improving patient care outcomes for diverse patient populations worldwide.
- Open Access
- 2 November 2024
- Published by Elsevier in JAAD Case Reports
- Vol. 55, 1-3
Painful pink papules and nodules presenting in a Blaskoid distribution
- 2 November 2024
- Published by Elsevier in JAAD Case Reports
- Vol. 55, 1-3
Open AccessPainful pink papules and nodules presenting in a Blaskoid distribution